255 related articles for article (PubMed ID: 36978408)
41. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.
Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N
Front Immunol; 2014; 5():180. PubMed ID: 24795723
[TBL] [Abstract][Full Text] [Related]
42. An Overview of Phytotherapeutic Approaches for the Treatment of Tuberculosis.
Sharma D; Yadav JP
Mini Rev Med Chem; 2017; 17(2):167-183. PubMed ID: 27145855
[TBL] [Abstract][Full Text] [Related]
43. Alginate-Capped Silver Nanoparticles as a Potent Anti-mycobacterial Agent Against
Chen CC; Chen YY; Yeh CC; Hsu CW; Yu SJ; Hsu CH; Wei TC; Ho SN; Tsai PC; Song YD; Yen HJ; Chen XA; Young JJ; Chuang CC; Dou HY
Front Pharmacol; 2021; 12():746496. PubMed ID: 34899300
[TBL] [Abstract][Full Text] [Related]
44. Engineering zinc oxide hybrid selenium nanoparticles for synergetic anti-tuberculosis treatment by combining Mycobacterium tuberculosis killings and host cell immunological inhibition.
Lin W; Fan S; Liao K; Huang Y; Cong Y; Zhang J; Jin H; Zhao Y; Ruan Y; Lu H; Yang F; Wu C; Zhao D; Fu Z; Zheng B; Xu JF; Pi J
Front Cell Infect Microbiol; 2022; 12():1074533. PubMed ID: 36776549
[TBL] [Abstract][Full Text] [Related]
45. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
[TBL] [Abstract][Full Text] [Related]
46. Drug-lead Anti-tuberculosis Phytochemicals: A Systematic Review.
Swain SS; Hussain T; Pati S
Curr Top Med Chem; 2021; 21(20):1832-1868. PubMed ID: 34225624
[TBL] [Abstract][Full Text] [Related]
47. A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren.
Ozeki Y; Igarashi M; Doe M; Tamaru A; Kinoshita N; Ogura Y; Iwamoto T; Sawa R; Umekita M; Enany S; Nishiuchi Y; Osada-Oka M; Hayashi T; Niki M; Tateishi Y; Hatano M; Matsumoto S
PLoS One; 2015; 10(11):e0141658. PubMed ID: 26571296
[TBL] [Abstract][Full Text] [Related]
48. Isoniazid derivatives and their anti-tubercular activity.
Hu YQ; Zhang S; Zhao F; Gao C; Feng LS; Lv ZS; Xu Z; Wu X
Eur J Med Chem; 2017 Jun; 133():255-267. PubMed ID: 28390957
[TBL] [Abstract][Full Text] [Related]
49. An Overview of Zinc Oxide Nanoparticles Produced by Plant Extracts for Anti-tuberculosis Treatments.
Behzad F; Sefidgar E; Samadi A; Lin W; Pouladi I; Pi J
Curr Med Chem; 2022; 29(1):86-98. PubMed ID: 34126883
[TBL] [Abstract][Full Text] [Related]
50. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
[TBL] [Abstract][Full Text] [Related]
51. The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection.
Marimani M; Ahmad A; Duse A
Tuberculosis (Edinb); 2018 Dec; 113():200-214. PubMed ID: 30514504
[TBL] [Abstract][Full Text] [Related]
52. Antimycobacterial evaluation and preliminary phytochemical investigation of selected medicinal plants traditionally used in Mozambique.
Luo X; Pires D; Aínsa JA; Gracia B; Mulhovo S; Duarte A; Anes E; Ferreira MJ
J Ethnopharmacol; 2011 Sep; 137(1):114-20. PubMed ID: 21571059
[TBL] [Abstract][Full Text] [Related]
53. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of Multi-Drug Resistant
Ali S; Khan MT; Khan AS; Mohammad N; Khan MM; Ahmad S; Noor S; Jabbar A; Daire C; Hassan F
Pol J Microbiol; 2020; 69(2):1-5. PubMed ID: 32249555
[TBL] [Abstract][Full Text] [Related]
55. Natural and trained innate immunity against Mycobacterium tuberculosis.
Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
[TBL] [Abstract][Full Text] [Related]
56. Anti-mycobacterial Constituents from Medicinal Plants; A Review.
Sarkar N; Dey YN; Kumar D; Rajagopal M
Mini Rev Med Chem; 2021; 21(19):3037-3051. PubMed ID: 34036911
[TBL] [Abstract][Full Text] [Related]
57. Traditional medicinal plants used in the treatment of tuberculosis in Ethiopia: A systematic review.
Getachew S; Medhin G; Asres A; Abebe G; Ameni G
Heliyon; 2022 May; 8(5):e09478. PubMed ID: 35647341
[TBL] [Abstract][Full Text] [Related]
58. Antioxidative and therapeutic potential of selected Australian plants: A review.
Mani JS; Johnson JB; Hosking H; Ashwath N; Walsh KB; Neilsen PM; Broszczak DA; Naiker M
J Ethnopharmacol; 2021 Mar; 268():113580. PubMed ID: 33189842
[TBL] [Abstract][Full Text] [Related]
59. Isoniazid-phytochemical conjugation: A new approach for potent and less toxic anti-TB drug development.
Swain SS; Paidesetty SK; Padhy RN; Hussain T
Chem Biol Drug Des; 2020 Aug; 96(2):714-730. PubMed ID: 32237023
[TBL] [Abstract][Full Text] [Related]
60. The resumption of consumption -- a review on tuberculosis.
Ducati RG; Ruffino-Netto A; Basso LA; Santos DS
Mem Inst Oswaldo Cruz; 2006 Nov; 101(7):697-714. PubMed ID: 17160276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
